Detalles de la búsqueda
1.
Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 Protocol.
Haematologica
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721737
2.
Sequelae and post-thrombotic syndrome after venous thromboembolism in acute lymphoblastic leukemia survivors treated on the NOPHO ALL2008 protocol.
Pediatr Blood Cancer
; 71(6): e30937, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480517
3.
Adequate immune responses to vaccines after chemotherapy for leukaemia diagnosed in childhood.
Acta Paediatr
; 113(3): 606-614, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38140806
4.
Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia.
Blood
; 137(17): 2373-2382, 2021 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33150360
5.
Obesity as a predictor of treatment-related toxicity in children with acute lymphoblastic leukaemia.
Br J Haematol
; 196(5): 1239-1247, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34726257
6.
Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia.
Blood
; 136(10): 1161-1168, 2020 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32391884
7.
Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes.
Haematologica
; 107(10): 2318-2328, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35354251
8.
Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol.
BMC Cancer
; 22(1): 483, 2022 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35501736
9.
Changes in body mass index during treatment of childhood acute lymphoblastic leukemia with the Nordic ALL2008 protocol.
Eur J Haematol
; 109(6): 656-663, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36006839
10.
Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype-genotype study.
Pediatr Blood Cancer
; 69(6): e29582, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316565
11.
TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia.
Pediatr Hematol Oncol
; 38(3): 227-238, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33205673
12.
Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.
Blood
; 131(22): 2475-2484, 2018 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29661787
13.
Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocols.
Eur J Haematol
; 105(6): 797-807, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32909636
14.
Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008.
Br J Haematol
; 184(3): 405-417, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30450575
15.
Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience.
Br J Haematol
; 184(6): 982-993, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30680711
16.
Use of granulocyte colony-stimulating factor and risk of relapse in pediatric patients treated for acute myeloid leukemia according to NOPHO-AML 2004 and DB AML-01.
Pediatr Blood Cancer
; 66(6): e27701, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30848067
17.
Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.
Pediatr Blood Cancer
; 66(5): e27594, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30592147
18.
Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature.
Genes Chromosomes Cancer
; 57(7): 359-365, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29569294
19.
Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study.
Br J Haematol
; 183(4): 618-628, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30406946
20.
Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial.
Eur J Haematol
; 100(1): 53-60, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28983968